Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.

MLA

Glotov, Andrey S., et al. “Targeted Next-Generation Sequencing (NGS) of Nine Candidate Genes with Custom AmpliSeq in Patients and a Cardiomyopathy Risk Group.” Clinica Chimica Acta, vol. 446, June 2015, pp. 132–40. EBSCOhost, https://doi.org/10.1016/j.cca.2015.04.014.

APA

Glotov, A. S., Kazakov, S. V., Zhukova, E. A., Alexandrov, A. V., Glotov, O. S., Pakin, V. S., Danilova, M. M., Poliakova, I. V., Niyazova, S. S., Chakova, N. N., Komissarova, S. M., Kurnikova, E. A., Sarana, A. M., Sherbak, S. G., Sergushichev, A. A., Shalyto, A. A., & Baranov, V. S. (2015). Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clinica Chimica Acta, 446, 132–140. https://doi.org/10.1016/j.cca.2015.04.014

Chicago

Glotov, Andrey S., Sergey V. Kazakov, Elena A. Zhukova, Anton V. Alexandrov, Oleg S. Glotov, Vladimir S. Pakin, Maria M. Danilova, et al. 2015. “Targeted Next-Generation Sequencing (NGS) of Nine Candidate Genes with Custom AmpliSeq in Patients and a Cardiomyopathy Risk Group.” Clinica Chimica Acta 446 (June): 132–40. doi:10.1016/j.cca.2015.04.014.